Rybelsus

rybelsus
rybelsus

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.

  • Active ingredient: Semaglutide
  • Best By: Jan 2026
  • Brand(s): Rybelsus
  • Manufacturer: Novo Nordisk India Pvt Ltd
  • Disease(s): Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus 3 mg

Per tablet Savings Price
10 tablet Per tablet$ 19.99 Price
$ 199.95
20 tablet Per tablet$ 18.00 $ 39.95 Price
$ 399.90 $ 359.95
30 tablet Per tablet$ 17.00 $ 89.90 Price
$ 599.85 $ 509.95
60 tablet Per tablet$ 16.00 $ 239.75 Price
$ 1199.70 $ 959.95
90 tablet Per tablet$ 15.00 $ 449.60 Price
$ 1799.55 $ 1349.95

Rybelsus 7 mg

Per tablet Savings Price
10 tablet Per tablet$ 19.99 Price
$ 199.95
20 tablet Per tablet$ 19.50 $ 9.95 Price
$ 399.90 $ 389.95
30 tablet Per tablet$ 19.00 $ 29.90 Price
$ 599.85 $ 569.95
60 tablet Per tablet$ 18.50 $ 89.75 Price
$ 1199.70 $ 1109.95
90 tablet Per tablet$ 18.00 $ 179.60 Price
$ 1799.55 $ 1619.95

Rybelsus 14 mg

Per tablet Savings Price
10 tablet Per tablet$ 23.99 Price
$ 239.95
20 tablet Per tablet$ 23.00 $ 19.95 Price
$ 479.90 $ 459.95
30 tablet Per tablet$ 22.50 $ 44.90 Price
$ 719.85 $ 674.95
60 tablet Per tablet$ 22.00 $ 119.75 Price
$ 1439.70 $ 1319.95
90 tablet Per tablet$ 21.50 $ 224.60 Price
$ 2159.55 $ 1934.95

Products from the same category

Product Information

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.